|
Craig A. Halverson has served as Vice President, Regulatory Affairs and Quality Assurance since January 2008. With over 20 years of experience in the biotechnology industry, Mr. Halverson is responsible for planning and executing global regulatory strategies, managing SciClone’s regulatory affairs and clinical operations for its Chinese business, and supervising quality assurance. Prior to joining SciClone, Mr. Halverson served as Vice President of Regulatory Affairs at ZymoGenetics from 2004-2007, Vice President of Regulatory Affairs and Quality Assurance at Introgen Therapeutics in 2004, Executive Director of Global Regulatory Affairs and Clinical Quality Assurance for Cancervax Corporation from 2001-2004, and Director of Regulatory Affairs at Gen-Probe Incorporated from 1998-2001. He also served as Global Regulatory Affairs Director for Baxter Healthcare Corporation’s Hyland Division from 1994-1998, worked in a number of Research, Regulatory Affairs, Technology Acquisition and Project Management positions of increasing responsibility for Hybritech, Inc. from 1985-1994 and held a number of academic research positions from 1975-1985. Mr. Halverson received his M.S.in Experimental Pathology from the University Southern California and his B.S. in Chemistry and Biology from California State University at Fullerton. | 